Global High Throughput Screening (HTS) Industry

NEW YORK, Nov. 23, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for High Throughput Screening (HTS) in US$ Million by the following Product Segments: Consumables/Reagents, Instruments, and Software and Services. The report also analyses the market by the following Technology Types: Label-Free Technology, Cell-Based Assay, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 104 companies including many key and niche players such as -

Agilent Technologies, Inc.
Aurora Biomed, Inc.
Axxam SpA
BD Biosciences
Danaher Corporation

Read the full report: http://www.reportlinker.com/p04368329-summary/view-report.html

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 Product Types.............. I-3 Consumables/Reagents..............I-4 Instruments.............. I-4 Software.............. I-4 Services.............. I-4 Technology Types.............. I-4 Label-Free Technology..............I-4 Cell-Based Assay..............I-4 Others.............. I-5

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW.............. II-1 High Throughput Screening (HTS): A Prelude II-1 HTS: The Mainstream Technology for Drug Discovery Programs II-2 Unparalleled Advantages in Compound Screening Drives Wider Adoption.............. II-2 Key Benefits of HTS - An Overview II-2 Investigate Vast Number of Modulators II-2 Accelerated Target Interrogation II-3 Generate Highly Relevant Data for Latter Stage Screening II-3 Scaling Efficiency..............II-3 Reduced Costs.............. II-3 Soaring R&D Spending Creates Conducive Environment for HTS II-3 Table 1: Healthcare Spending as a Percentage (%) of National GDP for Select Developed Nations (2014) (includes corresponding Graph/Chart)..............II-4

Table 2: Healthcare Spending as a Percentage (%) of National GDP for Select Developing Nations (2014) (includes corresponding Graph/Chart)..............II-5 Shift towards High Throughput Research Builds Momentum for HTS II-5 Upward Trajectory in Med Tech Sector Generates Parallel Opportunities.............. II-6 Assessing the Impact of Recent Economic Upheavals on HTS Market II-6 Stable Economic Outlook to Keep Market Sentiment Intact in the Near Term.............. II-7

2. KEY MARKET TRENDS & GROWTH DRIVERS II-9 Cell-based Assay: The Widely Used HTS Technology II-9 Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS..............II-9 HTS Aims to Expand Use Case in Biochemical Applications II-10 Label-Free HTS Demonstrates Fastest Growth II-10 Lab-on-a-Chip HTS Seeks to Proliferate the Market II-10 Bioinformatics HTS Enhanced with Computational Algorithms II-11 Positive Prognosis across End-Use Markets to Underpin Revenue Growth.............. II-11 Table 3: Global High Throughput Screening Market by End-Use Sector (2015): Percentage Breakdown of Revenues for Academia, Biotechnology, Contract Research Organizations (CROs), Government R&D, Pharmaceutical and Other Sectors (includes corresponding Graph/Chart)..............II-12 Pharmaceutical Industry Leads the Way II-12 HTS Deployments Soar in Academia II-13 Progressive Advancements in HTS Instruments Accelerate Market Growth.............. II-13 Microplate Handling Systems: An Important HTS Instrument Type II-14 Microplates.............. II-14 Microplate Readers..............II-14 Liquid Handling Devices: A Necessity in HTS Processes II-14 Microscopic Systems Facilitate Seamless Quantitative Analysis II-15 Advanced Software Platforms Augment HTS Proficiency II-15 Services: An Important Revenue Generating Segment II-15 Expansion in Compound Libraries Widens Functional Scope of HTS II-16 Compound Libraries Facilitate Simultaneous Functional Genomics & Small Molecule Analysis II-17 Laboratory Automation & Miniaturization Spell Opportunities for HTS.............. II-17 Miniaturization of Compound Screening Processes Drives Demand for HTS.............. II-17 HTS Miniaturization - Technology Developments II-18 HTS Robotics Support Miniaturization II-18 IVC - A Miniaturized, Powerful HTS Technology II-18 HTS Assumes Critical Importance in Target Identification & Validation.............. II-19 HTS Gathers Steam in Primary Screening Applications II-19 HTS Perceives Bright Future in Stem Cell Research II-20 HTS in Kinase Inhibitors Identification II-20 HTS in Alzheimer's Disease Drug Discovery II-20 HTS for Less Simplified PCR Systems II-21 HTFC Eases Metabolic Activity Analysis for Pharmaceutical Drugs II-21 Open Access Platforms Widen HTS Audience Base II-21 Need for Stringent QA System to Keep Failures at Bay II-21 High Throughput Screening (HTS) Vs. High Content Screening (HCS) II-22 Rise in Adoption of HCS Technology in HTS Laboratories II-22

3. PRODUCT OVERVIEW.............. II-24 High Throughput Research (HTR) II-24 High Throughput Screening (HTS)..............II-24 HTS Product Types.............. II-24 Consumables/Reagents..............II-24 Instruments.............. II-24 Software.............. II-24 Services.............. II-25 HTS Technologies.............. II-25 Label-Free Technology..............II-25 Cell-Based Assay.............. II-25 Others.............. II-25 HTS Process: An Overview..............II-25 Functional and Non-Functional - Two Types of High Throughput Assays.............. II-26 HTS: A Historical Perspective..............II-26

4. DRUG DISCOVERY - AN OVERVIEW..............II-28 Drug Discovery - Definition..............II-28 Drug Discovery Process..............II-28 Drug Discovery Technologies..............II-28 Computer Aided Drug Discovery (CADD) II-29 The Evolution of Computer Aided Drug Discovery (CADD) Processes II-29 High Throughput Screening..............II-29 Virtual Screening..............II-30 Cloud Computing.............. II-30 Hit and Lead Generation Strategies II-30 Different Stages in Hit and Lead Generation II-30 From 'Hit' to 'Lead' in HTS - A Complex Endeavor II-31

5. PRODUCT INNOVATIONS/INTRODUCTIONS II-32 BD Rolls Out BD CLiC™ System..............II-32 Molecular Devices Unveils Upgraded Version of MetaXpress® High-Content Image Acquisition and Analysis Software II-32 Crown Bioscience Unveils Huscreen™ High Throughput Oncology Service Platform.............. II-32 Catalent Pharma Solutions Extends OptiForm® Solution Suite for Macromolecule Rapid Screening II-32 OptraSCAN Unveils Subscription Scheme for High Throughput Whole Slide Imaging..............II-32 Core Informatics Unveils New Applications for Therapeutic Biologics Discovery & Development II-33 Horizon Discovery Introduces New High Throughput Platform for Immuno-Oncology Research..............II-33 Bruker Unveils MALDI PharmaPulse™ HTS Platform II-33 BellBrook Labs Launches TR-FRET Version of Transcreener UDP HTS Assay.............. II-33

6. RECENT INDUSTRY ACTIVITY..............II-34 AstraZeneca Collaborates with IntelliCyt II-34 Massachusetts General Hospital Teams Up with IntelliCyt II-34 Twist Bioscience Expands Collaboration with Ginkgo Bioworks II-34 Icagen Acquires Ultra High-Throughput Assets Sanofi II-34 Albany Molecular Research and New York Center for Nanomedicine Research Team Up.............. II-34 Genedata Extends License Deal with Ono Pharmaceutical II-34 IDBS and Cancer Research Technology Team Up II-35 PerkinElmer Acquires Vanadis Diagnostics II-35 Aptuit Acquires Exquiron Biotech II-35 BGI Selects Solvay's KetaSpire® PEEK for its BGISEQ-500 HTS System.............. II-35 Novogene and AITbiotech to Establish NovogeneAIT Genomics Singapore.............. II-35 Teva Pharmaceutical Industries Collaborates with AbCellera II-35 Merck Acquires Sigma-Aldrich..............II-36 JEOL USA Teams Up with IMRI..............II-36 CIRCE Teams Up with Freeslate..............II-36 Dow AgroSciences Inks License Agreement with Critical Path Services.............. II-36 TMG Collaborates with Verdeca..............II-36 Albany Molecular Research Signs Collaborative Agreement with Multispan.............. II-36 Cyprotex Inaugurates New HTS Laboratory in the US II-37 The Institut Pasteur Inks Partnership Agreement with IntegraGen II-37 Charles River Laboratories Acquires Oncotest II-37 Exquiron Inks Partnership Agreement with SAMDI Tech II-37 Vaccinogen Inks Option Agreement with Dublin City University II-37 Thermo Fisher Acquires Life Technologies II-37 Horizon Discovery to Acquire cHTS Service Business of Zalicus II-38 Axxam Collaborates with Cellectis Bioresearch II-38 Charles River to Acquire BioFocus and Argenta from Galapagos II-38

7. FOCUS ON SELECT GLOBAL PLAYERS..............II-39 Agilent Technologies, Inc. (US)..............II-39 Aurora Biomed, Inc. (Canada)..............II-39 Axxam SpA (Italy).............. II-39 BD Biosciences (US).............. II-40 Danaher Corporation (US)..............II-40 Beckman Coulter, Inc. (US)..............II-40 Molecular Devices Inc. (US)..............II-41 Bio-Rad Laboratories, Inc. (US)..............II-41 BioTek Instruments Inc. (US)..............II-42 BMG LABTECH GmbH (Germany)..............II-42 Charles River Laboratories International, Inc. (US) II-43 Corning Inc. (US).............. II-43 DiscoveRx Corporation (US)..............II-44 Evotec AG (Germany).............. II-44 F. Hoffmann-La Roche Ltd. (Switzerland) II-45 ForteBio (US).............. II-45 Genedata AG (Switzerland)..............II-45 IntelliCyt® Corporation (US)..............II-46 Luminex Corporation (US)..............II-46 PerkinElmer, Inc. (US)..............II-46 Sigma-Aldrich Corp. (US)..............II-47 Tecan Group Ltd. (Switzerland) II-47 Thermo Fisher Scientific Inc. (US) II-48

8. GLOBAL MARKET PERSPECTIVE..............II-49 Table 4: World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. II-49

Table 5: World Historic Review for High Throughput Screening (HTS) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) II-50

Table 6: World 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-51

Table 7: World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments, and Other Products Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) II-52

Table 8: World Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments, and Other Products Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-53

Table 9: World 14-Year Perspective for High Throughput Screening (HTS) by Product Type - Consumables/ Reagents, Instruments, and Other Products Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-54

Table 10: World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Technology Type - Label-Free Technology, Cell-Based Assay, and Other Technology Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. II-55

Table 11: World Historic Review for High Throughput Screening (HTS) by Technology Type - Label-Free Technology, Cell-Based Assay, and Other Technology Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) II-56

Table 12: World 14-Year Perspective for High Throughput Screening (HTS) by Technology Type - Label-Free Technology, Cell-Based Assay, and Other Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-57

III. MARKET

1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Market Overview.............. III-1 HTS Assumes Critical Importance in Drug Discovery Projects III-1 Spending on HTS Soars in Pharmaceutical Sector III-2 Cell-Based Assays Gain Popularity III-2 HTS Outsourcing Gathers Steam..............III-2 Product Launches..............III-3 Strategic Corporate Developments III-4 Key Players.............. III-7 B.Market Analytics..............III-14 Table 13: US Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-14

Table 14: US Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-15

2. CANADA.............. III-16 A.Market Analysis.............. III-16 Outlook.............. III-16 Key Player.............. III-16 B.Market Analytics..............III-17 Table 15: Canadian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-17

Table 16: Canadian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-18

3. JAPAN.............. III-19 A.Market Analysis.............. III-19 Outlook.............. III-19 Corporate Development..............III-19 B.Market Analytics..............III-20 Table 17: Japanese Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-20

Table 18: Japanese Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-21

4. EUROPE.............. III-22 A.Market Analysis.............. III-22 Outlook.............. III-22 Market Shifts Towards Maturity - Technological Innovations Come to the Rescue..............III-22 HTS in European Pharmaceutical Industry III-22 Clinical Trials Market in Europe III-23 Innovations in Cell Culture Drive Adoption of Cell-based Assay HTS.............. III-23 Label-Free Technologies Aim to Penetrate the Market III-23 B.Market Analytics..............III-24 Table 19: European Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-24

Table 20: European Historic Review for High Throughput Screening (HTS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-25

Table 21: European 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-26

4a. FRANCE.............. III-27 A.Market Analysis.............. III-27 Outlook.............. III-27 Strategic Corporate Developments III-27 B.Market Analytics..............III-28 Table 22: French Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-28

Table 23: French Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-29

4b. GERMANY.............. III-30 A.Market Analysis.............. III-30 Outlook.............. III-30 Corporate Development..............III-30 Key Players.............. III-30 B.Market Analytics..............III-31 Table 24: German Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-31

Table 25: German Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-32

4c. ITALY.............. III-33 A.Market Analysis.............. III-33 Outlook.............. III-33 Key Player.............. III-33 B.Market Analytics..............III-34 Table 26: Italian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-34

Table 27: Italian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-35

4d. THE UNITED KINGDOM..............III-36 A.Market Analysis.............. III-36 Outlook.............. III-36 Product Launch.............. III-36 Strategic Corporate Developments III-36 B.Market Analytics..............III-37 Table 28: The UK Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-37

Table 29: The UK Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-38

4e. SPAIN.............. III-39 Market Analysis.............. III-39 Table 30: Spanish Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-39

Table 31: Spanish Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-40

4f. RUSSIA.............. III-41 Market Analysis.............. III-41 Table 32: Russian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-41

Table 33: Russian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-42

4g. REST OF EUROPE.............. III-43 A.Market Analysis.............. III-43 Outlook.............. III-43 Strategic Corporate Developments III-43 Key Players.............. III-44 B.Market Analytics..............III-45 Table 34: Rest of Europe Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-45

Table 35: Rest of Europe Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-46

5. ASIA-PACIFIC.............. III-47 A.Market Analysis.............. III-47 Asia-Pacific Emerges as Fastest Growing Market for HTS III-47 Pharmaceutical & Biotech Industries Lead the Way III-47 B.Market Analytics..............III-48 Table 36: Asia-Pacific Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-48

Table 37: Asia-Pacific Historic Review for High Throughput Screening (HTS) by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-49

Table 38: Asia-Pacific 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-50

5a. CHINA.............. III-51 A.Market Analysis.............. III-51 Outlook.............. III-51 Opportunities in Expanding Chinese Life Sciences Sector III-51 Growing Drug Discovery Outsourcing Market Bodes Well for Market III-51 Few Problem Areas Exist..............III-51 What Outsourcers Need to Look Forward to III-52 Corporate Development..............III-52 B.Market Analytics..............III-53 Table 39: Chinese Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-53

Table 40: Chinese Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-54

5b. INDIA.............. III-55 A.Market Analysis.............. III-55 Market Overview.............. III-55 HTS Seeks Role in Indian Pharmaceutical Industry III-55 B.Market Analytics..............III-56 Table 41: Indian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-56

Table 42: Indian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-57

5c. REST OF ASIA-PACIFIC..............III-58 A.Market Analysis.............. III-58 Outlook.............. III-58 Corporate Development..............III-58 B.Market Analytics..............III-59 Table 43: Rest of Asia-Pacific Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-59

Table 44: Rest of Asia-Pacific Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-60

6. LATIN AMERICA.............. III-61 Market Analysis.............. III-61 Table 45: Latin American Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-61

Table 46: Latin American Historic Review for High Throughput Screening (HTS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-62

Table 47: Latin American 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-63

6a. BRAZIL.............. III-64 Market Analysis.............. III-64 Table 48: Brazilian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-64

Table 49: Brazilian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-65

6b. REST OF LATIN AMERICA..............III-66 Market Analysis.............. III-66 Table 50: Rest of Latin America Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-66

Table 51: Rest of Latin America Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-67

7. REST OF WORLD.............. III-68 A.Market Analysis.............. III-68 Outlook.............. III-68 Corporate Development..............III-68 B.Market Analytics..............III-69 Table 52: Rest of World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-69

Table 53: Rest of World Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-70

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 104 (including Divisions/Subsidiaries - 107)

The United States (64) Canada (2) Japan (2) Europe (34) - France (4) - Germany (7) - The United Kingdom (10) - Italy (1) - Spain (1) - Rest of Europe (11) Asia-Pacific (Excluding Japan) (5)
Read the full report: http://www.reportlinker.com/p04368329-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-high-throughput-screening-hts-industry-300368305.html

SOURCE Reportlinker